Cargando…

Novel production method of innovative antiangiogenic and antitumor small peptides in Escherichia coli

BACKGROUND: Developing innovative drugs with potent efficacy, specificity, and high safety remains an ongoing task in antitumor therapy development. In the last few years, peptide drugs have become attractive agents in cancer therapy. HM-3, mainly with antiangiogenic effect, and AP25, with an additi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Setrerrahmane, Sarra, Yu, Jian, Hao, Jingchao, Zheng, Heng, Xu, Hanmei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685134/ https://www.ncbi.nlm.nih.gov/pubmed/29184391 http://dx.doi.org/10.2147/DDDT.S136957

Ejemplares similares

Tumor-related interleukins: old validated targets for new anti-cancer drug development
por: Setrerrahmane, Sarra, et al.
Publicado: (2017)

Accurate control of dual-receptor-engineered T cell activity through a bifunctional anti-angiogenic peptide
por: Zhang, Erhao, et al.
Publicado: (2018)

Combination Therapy of PEG-HM-3 and Methotrexate Retards Adjuvant-Induced Arthritis
por: Hao, Jingchao, et al.
Publicado: (2017)

Integrins as attractive targets for cancer therapeutics
por: Li, Meng, et al.
Publicado: (2021)

Trends in insulin resistance: insights into mechanisms and therapeutic strategy
por: Li, Mengwei, et al.
Publicado: (2022)

Antiangiogenic and Antitumor Effects of Trypanosoma cruzi Calreticulin
por: López, Nandy C., et al.
Publicado: (2010)

Preclinical Evaluation of Discorhabdins in Antiangiogenic and Antitumor Models
por: Harris, Emily M., et al.
Publicado: (2018)

An antitumor peptide RS17‐targeted CD47, design, synthesis, and antitumor activity
por: Wang, Xinmin, et al.
Publicado: (2021)

Diclofenac Loaded Biodegradable Nanoparticles as Antitumoral and Antiangiogenic Therapy
por: Esteruelas, Gerard, et al.
Publicado: (2022)

Conjugation of VEGFR1/R2-targeting peptide with gold nanoparticles to enhance antiangiogenic and antitumoral activity
por: Zanjanchi, Pegah, et al.
Publicado: (2022)

Micropeptide MIAC inhibits the tumor progression by interacting with AQP2 and inhibiting EREG/EGFR signaling in renal cell carcinoma
por: Li, Mengwei, et al.
Publicado: (2022)

Experimental Evidence of the Antitumor, Antimetastatic and Antiangiogenic Activity of Ellagic Acid
por: Ceci, Claudia, et al.
Publicado: (2018)

Editorial: Are natural products, used as antitumoral/antiangiogenic agents, less toxic than synthetic conventional chemotherapy?
por: Nunez, Cecilia Veronica, et al.
Publicado: (2022)

Antitumor and Antiangiogenic Activities of Curcumin in Cervical Cancer Xenografts in Nude Mice
por: Yoysungnoen-Chintana, Pornphrom, et al.
Publicado: (2014)

Cell surface expression of nucleolin mediates the antiangiogenic and antitumor activities of kallistatin
por: Huang, Xiao-Ping, et al.
Publicado: (2017)

Photodynamic therapy – hypericin tetraether liposome conjugates and their antitumor and antiangiogenic activity
por: Plenagl, Nikola, et al.
Publicado: (2019)

The apatinib and pemetrexed combination has antitumor and antiangiogenic effects against NSCLC
por: Zhou, Ling, et al.
Publicado: (2023)

Physicochemical properties and in vitro cytotoxicity of iron oxide-based nanoparticles modified with antiangiogenic and antitumor peptide A7R
por: Niescioruk, Anna, et al.
Publicado: (2017)

Antiangiogenic Compound Axitinib Demonstrates Low Toxicity and Antitumoral Effects against Medulloblastoma
por: Pagnuzzi-Boncompagni, Marina, et al.
Publicado: (2021)

An Artificial Pathway for N-Hydroxy-Pipecolic Acid Production From L-Lysine in Escherichia coli
por: Luo, Zhou, et al.
Publicado: (2022)

Combining Antiangiogenic Therapy with Adoptive Cell Immunotherapy Exerts Better Antitumor Effects in Non-Small Cell Lung Cancer Models
por: Shi, Shujing, et al.
Publicado: (2013)

The combination of cantharidin and antiangiogenic therapeutics presents additive antitumor effects against pancreatic cancer
por: Xu, Meng-Dan, et al.
Publicado: (2018)

Enhancing Antitumor Immunity with Antiangiogenic Therapy: A Clinical Model in Renal Cell Carcinoma?
por: Gao, Xin, et al.
Publicado: (2019)

Antitumor and antiangiogenic activity of the novel chimeric inhibitor animacroxam in testicular germ cell cancer
por: Steinemann, Gustav, et al.
Publicado: (2019)

P32-specific CAR T cells with dual antitumor and antiangiogenic therapeutic potential in gliomas
por: Rousso-Noori, Liat, et al.
Publicado: (2021)

Novel Peptide CM 7 Targeted c-Met with Antitumor Activity
por: Xia, Chunlei, et al.
Publicado: (2020)

Optimization of the recombinant production and purification of a self-assembling peptide in Escherichia coli
por: Rad-Malekshahi, Mazda, et al.
Publicado: (2014)

Straightforward and Cost-Effective Production of RADA-16I Peptide in Escherichia coli
por: Fouani, Mohamad Hassan, et al.
Publicado: (2019)

Enhancing extracellular production of lipoxygenase in Escherichia coli by signal peptides and autolysis system
por: Pang, Cuiping, et al.
Publicado: (2022)

The Small Metal-Binding Protein SmbP Improves the Expression and Purification of the Recombinant Antitumor-Analgesic Peptide from the Chinese Scorpion Buthus martensii Karsch in Escherichia coli
por: Martinez-Mora, Evelyn, et al.
Publicado: (2022)

Comparison of Optimization-Modelling Methods for Metabolites Production in Escherichia coli
por: Lee, Mee K., et al.
Publicado: (2020)

Production of Lantipeptides in Escherichia coli
por: Shi, Yanxiang, et al.
Publicado: (2010)

Chemotherapeutic potentials of the stem bark of Balanite aegyptiaca (L.) Delile: an antiangiogenic, antitumor and antioxidant agent
por: Hassan, Loiy E. Ahmed, et al.
Publicado: (2016)

Polydopamine-coated gold nanostar for combined antitumor and antiangiogenic therapy in multidrug-resistant breast cancer
por: You, You-Hong, et al.
Publicado: (2019)

Pulsatile high-dose treatment with antiangiogenic tyrosine kinase inhibitors improves clinical antitumor activity
por: Rovithi, Maria, et al.
Publicado: (2017)

Improving antitumor immunity using antiangiogenic agents: Mechanistic insights, current progress, and clinical challenges
por: Li, Shu‐Jin, et al.
Publicado: (2021)

Small Molecule Neuropilin-1 Antagonists Combine Antiangiogenic and Antitumor Activity with Immune Modulation through Reduction of Transforming Growth Factor Beta (TGFβ) Production in Regulatory T-Cells
por: Powell, Jonathan, et al.
Publicado: (2018)

Rational Design of a Carrier Protein for the Production of Recombinant Toxic Peptides in Escherichia coli
por: Pane, Katia, et al.
Publicado: (2016)

Effects of Signal Peptide and Chaperone Co-Expression on Heterologous Protein Production in Escherichia coli
por: Jomrit, Juntratip, et al.
Publicado: (2023)

Advances in antiangiogenic treatment of small-cell lung cancer
por: Lu, Hongyang, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0m5qrtqo02n0h8ljh0ukmetp4n